# Study on Tolerability of Repeat i.c.v. Administration of sNN0031 Infusion Solution in Patients With PD

> **NCT02408562** · PHASE1,PHASE2 · TERMINATED · sponsor: **Newron Sweden AB** · enrollment: 1 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **OTHER:** i.c.v. infusion of sNN0031 by an Implanted infusion system
- **OTHER:** i.c.v. infusion of aCSF by an Implanted infusion system

## Key facts

- **NCT ID:** NCT02408562
- **Lead sponsor:** Newron Sweden AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-01
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Issues with development and supply of infusion system for delivery of IMP. Prolonged approval process for the clinical study sNN0031-004.
- **Last updated:** 2016-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02408562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02408562, "Study on Tolerability of Repeat i.c.v. Administration of sNN0031 Infusion Solution in Patients With PD". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02408562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*